A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris
NCT03127956
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
748
Enrollment
INDUSTRY
Sponsor class
Conditions
Acne Vulgaris
Interventions
DRUG:
Olumacostat Glasaretil Gel, 5.0%
Sponsor
Dermira, Inc.